Dermatomyositis Terminated Phase 2 / 3 Trials for Etanercept (DB00005)

Also known as: Dermatomyositides / Dermatopolymyositis, unspecified

IndicationStatusPhase
DBCOND0002234 (Dermatomyositis)Terminated2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00035958Understanding the Pathogenesis and Treatment of Childhood Onset DermatomyositisTreatment